Maclean and Jansen Advocate for Open-Source Modeling in Pharmaceutical Executive

Precision’s Ross Maclean and Jeroen Jansen encourage biopharma and medical device industries to embrace the developments around value assessment and to take a leading role in improving the transparency of cost-effectiveness evaluations. 

To read the full article, please click here.